NovaBay Pharmaceuticals (NBY) Swings to Q4 Loss on Lighter Revs
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q4 EPS of ($0.13), versus $0.01 reported last year. Revenue for the quarter came in at $1.23 million, versus $3.04 million reported last year.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
